Recruiting
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
NCT06518005
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crigler-Najjar Syndrome, Genetic Diseases, Inborn, +4 more
- Locations
-
- Hopital Antoine BECLERE Clamart, France